Downstream Processing Market Size, Share, Trends, Application Analysis and Growth by Forecast to 2022-2032
The global Downstream Processing Market was valued at US$ 22.0 billion in 2021 and is predicted to reach US$ 24.9 billion by the end of 2022.
Furthermore, with increasing use among biopharmaceutical enterprises and contract research organisations, global demand for downstream processing goods is expected to grow at an 11.3% CAGR between 2022 and 2032, totaling a market worth of US$ 72.3 Bn by 2032.
Downstream processing is used to
manufacture antibiotics, antibodies, hormones, vaccines and also used for the
production of industrial enzymes. In downstream processing, the purification
and recovery of biosynthetic products is done that are derived from natural
sources such as tissues of animals and plants.
The
downstream processing market demand is fuelled by the ever growing demand
for biopharmaceuticals and increasing R&D spending on the development of
such products. However, the high cost of the instruments involved in downstream
processing and a dearth of skilled workforce is hampering the growth of this
market.
Access Full Report: https://www.futuremarketinsights.com/reports/downstream-processing-market
Forecast Highlights on Global
Downstream Processing Market
- As per the forecast of Future Market
Insights, the filters product type segment is slated to touch a value of
nearly US$ 5,700 Mn in the year 2022. This represents a robust CAGR during
the assessment period of 2017-2022. The filters product type segment is
estimated to account for more than one-fifth of the revenue share of the
product type segment by the year 2017 and is forecasted to lose market
share by 2022 over 2017.
- As per the forecast of Future Market
Insights, the contract manufacturing organizations segment will reach a
value of nearly US$ 5,500 Mn in the year 2017. This represents a robust
CAGR growth during the forecast period. The contract manufacturing
organizations segment is forecasted to account for more than one-third of
the total revenue share of the end users segment by the end of the year
2017 and is expected to lose in market share by 2022 as compared with the
year 2017.
- As per the forecast of Future Market Insights,
the monoclonal antibody production segment is slated to reach a value of
about US$ 8,300 Mn in 2022. The monoclonal antibody production segment is
expected to gain market share by the end of the year 2022. The largest
share is contributed by the North America region in the monoclonal
antibody production segment.
- Future Market Insights forecasts the gel
chromatography segment to exhibit a compound annual growth rate (CAGR) of
nearly 15.0% from 2017 to 2022.
The
report has also included the profiles of some of the leading companies in the
downstream processing market like Sartorius Aktiengesellschaft, Repligen
Corporation, Merck & Co Inc., Thermo Fisher Scientific, Inc., Eppendorf AG, General Electric Company,
Corning Incorporated, 3M Company, Lonza Group Ltd. and Danaher Corporation.
Comments
Post a Comment